Ling Jin

发表

Discovery of a novel bicycloproline P2 bearing peptidyl alpha-ketoamide LY514962 as HCV protease inhibitor.

J. Glass, B. Heinz, Q. Wang, 2004, Bioorganic & medicinal chemistry letters.

A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti–Interleukin‐17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors

M. Genovese, D. Braun, G. Cameron, 2014, Arthritis & rheumatology.

A randomized trial of edivoxetine in pediatric patients with attention-deficit/hyperactivity disorder.

C. Kratochvil, A. Allen, D. D'souza, 2014, Journal of child and adolescent psychopharmacology.

Clinical outcomes from an open-label study of edivoxetine use in pediatric patients with attention-deficit/hyperactivity disorder.

A. Allen, S. Tauscher‐Wisniewski, W. Kielbasa, 2013, Journal of child and adolescent psychopharmacology.

Seizure risk in patients with attention‐deficit‐hyperactivity disorder treated with atomoxetine

J. Wernicke, S. Ball, D. Dunn, 2007, Developmental medicine and child neurology.

Retrospective safety analysis of atomoxetine in adult ADHD patients with or without comorbid alcohol abuse and dependence.

T. Wilens, P. Trzepacz, L. Adler, 2009, The American journal on addictions.

Hepatic Events Associated with Atomoxetine Treatment for Attention-Deficit Hyperactivity Disorder

J. Wernicke, A. Allen, Shuyu Zhang, 2008, Drug safety.

A meta-analysis of the consistency of atomoxetine treatment effects in pediatric patients with attention-deficit/hyperactivity disorder from 15 clinical trials across four geographic regions.

L. Rohde, H. Upadhyaya, P. Feldman, 2013, Journal of child and adolescent psychopharmacology.

Safety and tolerability of atomoxetine over 3 to 4 years in children and adolescents with ADHD.

T. Spencer, P. Trzepacz, M. Witte, 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers

M. Mitchell, H. Haber, A. Allen, 2013, British journal of clinical pharmacology.

[Wuling Capsule for climacteric patients with depression and anxiety state: a randomized, positive parallel controlled trial].

Qingyan Zou, Ling Jin, Ji Li, 2009, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

Pharmacokinetics and pharmacodynamics of edivoxetine (LY2216684), a norepinephrine reuptake inhibitor, in pediatric patients with attention-deficit/hyperactivity disorder.

W. Kielbasa, T. Quinlan, Ling Jin, 2012, Journal of child and adolescent psychopharmacology.

Retrospective safety analysis of atomoxetine in adult ADHD patients with or without comorbid alcohol abuse and dependence.

T. Wilens, P. Trzepacz, L. Adler, 2009, The American journal on addictions.

Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers

P. Kothare, M. Mitchell, H. Haber, 2013, British journal of clinical pharmacology.